PT3737403T - Adenovírus modificados - Google Patents

Adenovírus modificados

Info

Publication number
PT3737403T
PT3737403T PT197111578T PT19711157T PT3737403T PT 3737403 T PT3737403 T PT 3737403T PT 197111578 T PT197111578 T PT 197111578T PT 19711157 T PT19711157 T PT 19711157T PT 3737403 T PT3737403 T PT 3737403T
Authority
PT
Portugal
Prior art keywords
modified adenoviruses
adenoviruses
modified
Prior art date
Application number
PT197111578T
Other languages
English (en)
Original Assignee
Univ College Cardiff Consultants Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ College Cardiff Consultants Ltd filed Critical Univ College Cardiff Consultants Ltd
Publication of PT3737403T publication Critical patent/PT3737403T/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/76Viruses; Subviral particles; Bacteriophages
    • A61K35/761Adenovirus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/10011Adenoviridae
    • C12N2710/10311Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10321Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/10011Adenoviridae
    • C12N2710/10311Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10322New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/10011Adenoviridae
    • C12N2710/10311Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10332Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/10011Adenoviridae
    • C12N2710/10311Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10341Use of virus, viral particle or viral elements as a vector
    • C12N2710/10345Special targeting system for viral vectors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
PT197111578T 2018-02-16 2019-02-13 Adenovírus modificados PT3737403T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1802539.5A GB201802539D0 (en) 2018-02-16 2018-02-16 Modified adenoviruses

Publications (1)

Publication Number Publication Date
PT3737403T true PT3737403T (pt) 2024-01-24

Family

ID=61783770

Family Applications (1)

Application Number Title Priority Date Filing Date
PT197111578T PT3737403T (pt) 2018-02-16 2019-02-13 Adenovírus modificados

Country Status (16)

Country Link
US (1) US12318418B2 (pt)
EP (1) EP3737403B1 (pt)
JP (3) JP2021513843A (pt)
KR (1) KR102687425B1 (pt)
CN (2) CN112020368B (pt)
AU (1) AU2019220607B2 (pt)
CA (1) CA3090859C (pt)
DK (1) DK3737403T5 (pt)
ES (1) ES2968387T3 (pt)
FI (1) FI3737403T3 (pt)
GB (1) GB201802539D0 (pt)
IL (1) IL276535B2 (pt)
PL (1) PL3737403T3 (pt)
PT (1) PT3737403T (pt)
SG (1) SG11202007470QA (pt)
WO (1) WO2019158914A1 (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2014236207B2 (en) 2013-03-14 2019-05-23 Salk Institute For Biological Studies Oncolytic adenovirus compositions
KR20250081944A (ko) 2014-09-24 2025-06-05 솔크 인스티튜트 포 바이올로지칼 스터디즈 종양 살상 바이러스 및 이의 사용방법
WO2017147265A1 (en) 2016-02-23 2017-08-31 Salk Institute For Biological Studies High throughput assay for measuring adenovirus replication kinetics
EP4155411A1 (en) 2016-02-23 2023-03-29 Salk Institute for Biological Studies Exogenous gene expression in therapeutic adenovirus for minimal impact on viral kinetics
EP3532082A4 (en) 2016-12-12 2020-08-26 Salk Institute for Biological Studies SYNTHETIC ADENOVIRUS TUMOR TARGETING AND THEIR USES
MX2020010499A (es) 2018-04-09 2020-10-28 Salk Inst For Biological Studi Composiciones de adenovirus oncoliticas con propiedades aumentadas de replicacion.
EP3812465A1 (en) * 2019-10-21 2021-04-28 Universität Ulm Adenovirus comprising a modified adenovirus hexon protein
CN115605586B (zh) * 2020-04-07 2024-09-06 深圳市华药康明生物药业有限责任公司 工程化溶瘤腺病毒
US20240180982A1 (en) * 2021-03-29 2024-06-06 University College Cardiff Consultants Limited Modified adenovirus
GB202214580D0 (en) 2022-10-04 2022-11-16 Univ College Cardiff Consultants Ltd Adenoviral vector therapy
GB202314435D0 (en) 2023-09-20 2023-11-01 Univ College Cardiff Consultants Ltd Modified adenovirus

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003062400A2 (en) 2002-01-24 2003-07-31 The Scripps Research Institute Fiber shaft modifications for efficient targeting
CA2519680A1 (en) 2003-03-28 2004-11-18 The Scripps Research Institute Adenovirus particles with enhanced infectivity of dendritic cells and particles with decreased infectivity of hepatocytes
GB0520068D0 (en) * 2005-10-03 2005-11-09 Cancer Res Technology av peptide ligand
ATE510907T1 (de) * 2007-03-14 2011-06-15 Inst Catala D Oncologia Adenovirus mit mutationen in der domäne des e3- 19k-proteins zur retention im endoplasmatischen retikulum und verwendung in der krebsbehandlung
CN102014948A (zh) * 2008-02-07 2011-04-13 安德鲁·贝克 腺病毒向性的调节
RU2013118724A (ru) * 2010-09-24 2014-10-27 Онкос Терапьютикс Ой Онколитические аденовирусные векторы и связанные с ними способы и применения
EP3247807B1 (en) * 2015-01-20 2020-12-16 Adcure Biotechnologies, LLC. Detargeted adenovirus variants and related methods

Also Published As

Publication number Publication date
JP2025081522A (ja) 2025-05-27
CA3090859C (en) 2025-04-01
EP3737403A1 (en) 2020-11-18
US12318418B2 (en) 2025-06-03
JP2021513843A (ja) 2021-06-03
DK3737403T3 (da) 2024-01-22
KR20200122346A (ko) 2020-10-27
WO2019158914A1 (en) 2019-08-22
EP3737403B1 (en) 2024-01-03
CN118834841A (zh) 2024-10-25
AU2019220607B2 (en) 2024-02-15
CN112020368B (zh) 2024-07-12
FI3737403T3 (fi) 2024-01-17
IL276535B2 (en) 2025-07-01
DK3737403T5 (da) 2024-08-26
IL276535A (en) 2020-09-30
PL3737403T3 (pl) 2024-03-18
JP2024020345A (ja) 2024-02-14
CA3090859A1 (en) 2019-08-22
ES2968387T3 (es) 2024-05-09
AU2019220607A1 (en) 2020-09-17
CN112020368A (zh) 2020-12-01
GB201802539D0 (en) 2018-04-04
IL276535B1 (en) 2025-03-01
KR102687425B1 (ko) 2024-07-22
SG11202007470QA (en) 2020-09-29
US20210100855A1 (en) 2021-04-08

Similar Documents

Publication Publication Date Title
FIC20253006I1 (fi) Linvoseltamabi
FIC20260010I1 (fi) imlunestrantti
EP3890716A4 (en) COMBINATION THERAPIES
EP3846674C0 (en) VAGINAL SPECULUM
EP3849534A4 (en) COMBINATION THERAPIES
EP3555124C0 (en) TCR NYESO
EP3976075A4 (en) MODIFIED ADENOVIRUS
PT3737403T (pt) Adenovírus modificados
EP3781060A4 (en) CRYOPROBE
EP3784463A4 (en) Fluorosulfones
EP3872558A4 (en) OPTICAL ISOLATOR
EP3810860C0 (en) COUPLER
EP3792200A4 (en) TANK TANK
EP3745904C0 (de) Stockgriff
EP3878374A4 (en) Occlusion device
EP3721129C0 (en) Cryosphere
EP3844177A4 (en) COMBINATION THERAPIES
DK3587968T3 (da) Fluidsystem
EP3773733C0 (en) METALLO-LIOTHYRONINE
EP3787554A4 (en) STENT TRANSPLANT
DK3752258T3 (da) Trampolin
EP3738602A4 (en) CYTOCIDE
ES1207586Y (es) Furgo-caravana
EP3787995C0 (en) HARNESS SADDLE
MA49925A (fr) Claie